Related Experiment Video
Updated: Mar 8, 2026

10:42
Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
Published on: October 22, 2012
16.8K
Visualization and Quantification of Browning Using a Ucp1-2A-Luciferase Knock-in Mouse Model
Liufeng Mao1, Baoming Nie2, Tao Nie1
1CAS Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Medical University, and Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Diabetes
|January 22, 2017
Summary
Researchers developed a Ucp1-2A-luciferase mouse to study brown and beige adipocytes. This model revealed a new ear adipose depot and identified axitinib as a potential obesity treatment by promoting
Area of Science:
- Metabolic research
- Adipose tissue biology
- Obesity and metabolic disease research
Background:
- Brown and beige adipocytes are crucial for energy expenditure and combating metabolic diseases.
- Uncoupling protein 1 (Ucp1) is a key marker for brown and beige adipocyte function.
- Accurate measurement of Ucp1 expression is vital for studying thermogenesis.
Purpose of the Study:
- To develop a sensitive tool for measuring Ucp1 expression in vivo and in vitro.
- To identify novel adipose tissue depots and potential therapeutic agents for obesity.
Main Methods:
- Generation of a Ucp1-2A-luciferase knock-in mouse model.
- Utilizing luciferase activity for quantitative and visualization studies of Ucp1 expression.
- Screening for compounds that induce 'browning' of adipose tissue.
Main Results:
- The Ucp1-2A-luciferase mouse model accurately reflects Ucp1 gene expression.
- Discovery of a novel, cold-sensitive brown/beige adipose depot in the ear (uBAT).
- Identification of axitinib as an effective 'browning' agent.
Conclusions:
- The Ucp1-2A-luciferase mouse is a valuable tool for studying thermogenesis and adipocyte function.
- The uBAT depot represents a new area for metabolic research.
- Axitinib shows promise as a therapeutic agent for obesity and related metabolic disorders.

